Recent randomized controlled trials have suggested that patients with ST-segment elevation
myocardial infarction and multivessel coronary artery disease may benefit more from …

Objectives: The authors conducted a systematic pairwise and network meta-analysis to
assess optimal treatment strategies in patients with ST-segment elevation myocardial …

Current guidelines recommend against revascularization of the noninfarct artery during the
index percutaneous coronary intervention (PCI) in hemodynamically stable patients with ST …

Approximately 50% of patients with ST-segment elevation myocardial infarction (STEMI)
have multivessel disease. The optimal reperfusion strategy in these patients is still uncertain …

Objectives: This study evaluated revascularization strategies for patients with ST-segment
elevation myocardial infarction (STEMI) and multivessel disease. Background: In patients …

急性心肌梗死是具有较高致死致残率的心血管危重症. 早期进行血运重建及有效的心肌保护是
改善患者预后的重要手段. 随着药物及器械的进步, 对于合并多支血管病变的急性心肌梗死的 …

Background A significant portion of patients with ST-elevation myocardial infarction (STEMI)
display multivessel coronary artery disease. However, data on the association of multivessel …

Backgroundand objective Studies have highlighted the significant role of staged
percutaneous coronary intervention (PCI) for a multivessel disease (MVD) among patients …

ST-segment elevation myocardial infarction (STEMI) patients with multivessel disease
(MVD) have a higher incidence of slow-flow/no-reflow (SF-NR) phenomenon during primary …

Background The best strategy for the treatment of the non-infarct artery in patients with ST-
elevation myocardial infarction (STEMI) and multivessel disease (MVD) undergoing primary …